On August 4, 2023, Fred Kurland resigned as Chief Financial Officer of Aridis Pharmaceuticals, Inc. due to his retirement. Mr. Kurland will serve as senior financial consultant to the Company. The Company?s Vice President of Finance, Ms. Tamara Allen, continues to lead all aspects of financial accounting and reporting.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.059 USD | +4.42% | 0.00% | -15.83% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.83% | 2.71M | |
+2.97% | 108B | |
+10.21% | 105B | |
+1.57% | 23.46B | |
-12.77% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.50% | 17.19B | |
+6.00% | 13.99B | |
+37.20% | 12.53B |
- Stock Market
- Equities
- ARDS Stock
- News Aridis Pharmaceuticals, Inc.
- Aridis Pharmaceuticals, Inc. Announces Resignation as Chief Financial Officer